United States Fibroblast Growth Factors (FGFs) Market Set for Rapid Growth Amid Rising Therapeutic Applications 2025 | Top key players - Amgen Inc., Johnson & Johnson, Eisai Co., Ltd.

Market Size and Growth:

The Global Fibroblast Growth Factors (FGFs) Market reached US$ 303.75 million in 2024 and is expected to reach US$ 598.06 million by 2033, growing at a CAGR of 8.2% during the forecast period 2025-2033

The Fibroblast Growth Factors Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/fibroblast-growth-factors-market?sz

The Fibroblast Growth Factors (FGFs) Market encompasses the research, development, and commercialization of FGFs, which are proteins crucial for cell growth, tissue repair, angiogenesis, and wound healing. The market includes recombinant FGFs, therapeutic applications in regenerative medicine, oncology, and chronic disease treatment, as well as associated biopharmaceutical products, research tools, and clinical development services.

Recent Key Developments of United States (U.S):

September 18, 2025: Roche signed an agreement to acquire 89bio for up to $3.5 billion. The deal includes 89bio's lead product, pegozafermin, an FGF21 analogue, which is in late-stage trials for Metabolic Dysfunction-associated Steatohepatitis (MASH).

August 19, 2025: A market report highlighted that the North American FGFs market, driven by regenerative medicine, is projected to maintain a strong growth trajectory with a CAGR of 8.67% during the 2025-2034 forecast period.

August 2025: Continuing growth in the regenerative medicine and aesthetics segment was projected to grow at a significant CAGR, while the preclinical use segment maintained the major market share by regulation/clinical stage.

July - September 2025: Increased focus on Artificial Intelligence (AI) application in the FGF market, particularly for drug discovery and development, to accelerate identification of drug candidates and optimize development processes.

July - September 2025: Continued research and clinical progress in FGF-targeting therapies for conditions like X-linked hypophosphatemia (XLH), with drugs like Crysvita (burosumab, an anti-FGF23 antibody) remaining key products in the market.

List of the Key Players in the Fibroblast Growth Factors Market:

Amgen Inc.
Thermo Fisher Scientific Inc.
Johnson & Johnson
Tyra Biosciences, Inc.
Eisai Co., Ltd.
Alnylam Pharmaceuticals, Inc.
Relay Therapeutics
Abbisko Therapeutics Co, Ltd
BridgeBio Pharma, Inc.
Incyte.
TAIHO PHARMACEUTICAL CO., LTD.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=fibroblast-growth-factors-market

Segments Covered in the Fibroblast Growth Factors Market:

By Type: Palifermin, Erdafitinib, Infigratinib, Futibatinib, Others.

By Application: Oncology, Hematology, Wound Healing, Dermatology, Cardiovascular Disease, Bone Disorders, Musculoskeletal Disorders, Tissue Regeneration, Others.

By End-User: Pharmaceutical and Biotechnology Companies, Research Centers & Academic Institutes, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/fibroblast-growth-factors-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Fibroblast Growth Factors market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Fibroblast Growth Factors Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Fibroblast Growth Factors market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Fibroblast Growth Factors Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Fibroblast Growth Factors Market in 2025?
◆ What is the projected growth rate of the Fibroblast Growth Factors Market through 2033?
◆ Who are the key players in the Fibroblast Growth Factors Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.